Category: General News
Search News
NHS Innovation Accelerator
5th March 2019
Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts Health NHS Trust, was announced today as one of 13 Fellows to join the NHS […]
Read more
Flying in the face of cancer
27th February 2019
Using flies to reveal mechanisms of cancer development- Q&A with Dr Ribeiro Dr Paulo Ribeiro and his team. From left to right: Paulo Ribeiro, Lauren Dawson, Alberto Rizzo and Damien […]
Read more
BCI scientist visits politicians in Westminster
20th February 2019
Dr John Riches from our Centre for Haemato-Oncology swapped a lab coat for legislation when he visited Zoë Grunewald (Second Clerk – Commons Science and Technology Committee) at the House of Commons for a week in Westminster. The week (26-30th November 2018) was part of a unique pairing scheme run by the Royal Society.
Read more Treatment for advanced kidney cancer
13th February 2019
A combination therapy has shown powerful anticancer responses in patients with a type of advanced kidney cancer in a new international phase III clinical trial (KEYNOTE-426). Treatment with the combination therapy resulted in significant increases in overall survival when compared with the current standard of care, and the findings will help to provide a vital new treatment option for patients with this disease.
Read more
Tackling tumour scar tissue could be key to treating pancreatic cancer
11th February 2019
The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.
Read more
World Cancer Day 2019
4th February 2019
Today is World Cancer Day- an initiative led by the Union for International Cancer Control that marks a day on which the entire world can unite in the fight against cancer. Find out how we are collaborating with scientists from around the world to accelerate progress in cancer research.
Read more